A prefilled syringe is a single-dose packet of vaccine to which a needle has been fixed by the manufacturer.
Europe has seen the fastest update of devices and currently accounts for approximately 45% of all pre-fills consumed. The US has been slower to convert from traditional syringes and vials, but this trend is reversing and the US is currently the fastest-growing market, accounting for 35% of unit volumes in 2013. Representing 5% of the market, Japan is unique in that it has been a rapid adopter of plastic devices, which account for approximately 65% of all pre-filled syringes sold in the country, whereas more than 95% of those sold in other regions are manufactured from glass.

According to this study, over the next five years the Pre-Filled Syringe (Prefilled Syringe) market will register a xx% CAGR in terms of revenue, the global market size will reach USD xx million by 2024, from USD xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pre-Filled Syringe (Prefilled Syringe) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Filled Syringe (Prefilled Syringe) market by product type, application, key manufacturers and key regions and countries.

This study considers the Pre-Filled Syringe (Prefilled Syringe) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Glass Pre-Filled Syringes
Plastic Pre-Filled Syringes
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Vaccines
Monoclonal Antibodies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BD
Gerresheimer
Schott
Baxter
Nipro
Ompi(Stevanato Group)
Weigao
Unilife
Roselabs
Vetter Pharma
National Medical Products
Robert Bosch GmbH
Owen Mumford
Ypsomed
SHL Group
Bespak
ROVI CM
Terumo
Taisei Kako Co.
ARTE CORPORATION

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pre-Filled Syringe (Prefilled Syringe) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pre-Filled Syringe (Prefilled Syringe) market by identifying its various subsegments.
Focuses on the key global Pre-Filled Syringe (Prefilled Syringe) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pre-Filled Syringe (Prefilled Syringe) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pre-Filled Syringe (Prefilled Syringe) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.